TGFβ directly targets cytotoxic T cells (CTLs) through transcriptional repression of cytotoxic genes, such as perforin, granzyme A, granzyme B, IFN-γ and FasL, resulting in tumour cell escape from immunosurveillance [78]. The gene discussed is TGFB1; the disease is neoplasm.